Pfizer Essential Health Is Staying Put And Has A Focused Strategy For Growth

With a new name and focused strategy, Pfizer’s Essential Health business has evolved since the acquisition of Hospira in 2015. Group President John Young outlined the company’s plans to transition a unit that was established to manage patent expirations to become a growth center.

More from Strategy

More from Business